Skip to content
Nonprofiteer
← All organizations

BIO VENTURES FOR GLOBAL HEALTH

EIN 30-0213137 SEATTLE, WA

Largest nonprofits in Washington

Revenue 2024
$504,858
Expenses 2024
$2,591,563

Program services were 69.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

As filed

Subsection
03
NTEE code
E120
Classification
1000
Street
2101 4TH AVE STE 1950

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Mission and programs · 2024

Mission

BVGH drives sustainable, market-informed solutions to improve access to quality healthcare in low- and middle-income countries. BVGH builds cross-sector partnerships that align industry, government, and local health-system priorities to expand access to cancer care, infectious disease technologies, and essential medicines. BVGHs flagship programs focus on strengthening cancer and infectious disease ecosystems through coordinated national strategies, capacity building, and responsible product introduction. Key activities include the African Access Initiative (AAI), which supports countries in developing cancer control plans, expanding diagnostics and treatment capacity, and improving affordability and availability of oncology products. BVGH also brokers collaborations between companies and African research institutions to advance R&D, clinical trials, workforce training, and technology transfer. These activities collectively enhance health-system readiness, accelerate access to lifesavi

Activities or mission (Part I)

BVGH builds partnerships to expand access to healthcare in LMICs, by strengthening health systems, coordinating national planning, building capacity, and managing procurement. Its work aligns and informs government and industry strategies and policies.

  • African Access Initiative (AAI): A PPP that targets the cancer crisis in Africa. Through AAI, BVGH is strengthening healthcare systems, building oncology capacity and skills, forging research and development partnerships led by African healthcare professionals, building and promoting clinical trial readiness, and creating community awareness and promoting health education. AAI has trained more than 18,000 oncology healthcare professionals, delivered access to multiple cancer medicines, and forged countless partnerships.

    Expenses $1,631,966

  • BVGH Other Programs: BVGH develops and manages programs that advance LMIC government objectives as they relate to: public-private partnership development; strategic and implementation planning development; program implementation and management; and international partner program management (across research, health systems strengthening, workforce development, and climate and agriculture as they intersect with health). BVGH develops market assessment and entry reports for the private sector to inform short and long-term investments and decision making. Market reports include: economic and country stability and risk assessment; country SWOT analysis; market and growth potential; regulatory and payor systems analysis; innovative financing opportunities; stakeholder mapping; and more. Other programs include: laboratory and medtech systems placement, delivery, and training.

    Expenses $87,204

  • BVGH Infectious Disease Programs (Global Innovation Alliance (GIA) and Global Innovation Alliance Network of Trial Sites (GIANTS)): BVGH catalyzes and manages global cross-organization, cross-sector collaborations to advance research and development (R&D) targeting infectious diseases with high burdens in LMICs. Through the Global Innovation Alliance (GIA), BVGH: 1.) builds and manages R&D collaborations between LMIC scientists and global partners; 2.) assesses, promotes, and fosters clinical trial capacity and inclusion in LMICs; 3.) elevates scientific expertise in LMICs through tailored capacity building programs; and 4.) evaluates and communicates program outcomes and impacts to broad and targeted global audiences. The programs strengthen laboratory capacity, support technology transfer, and advance co-developed R&D initiatives for vaccines, therapeutics, and diagnostics. By integrating country-level health system knowledge with real-world implementation data, BVGH helps partners accelerate innovation and prepare for feasible adoption pathways. This work contributes to more resilient infectious disease response systems and informed policy decision-making.

    Expenses $86,143

As filed on the 2024 return.

Officers and directors · 2024

As listed in Part VII of the 2024 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

  • Jennifer Dent

    President & CEO

    Total calculated
    $486,109
    From this org
    $433,705
    From related orgs
    $0
    Other
    $52,404
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $343,705
    Bonus
    $90,000
    Other
    not reported
    Deferred
    $17,248
    Nontaxable benefits
    $35,156
    Filer's total
    $486,109
  • Katy Graef

    Vice President Programs

    Total calculated
    $208,226
    From this org
    $190,233
    From related orgs
    $0
    Other
    $17,993
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $190,233
    Bonus
    not reported
    Other
    not reported
    Deferred
    $9,512
    Nontaxable benefits
    $8,481
    Filer's total
    $208,226
  • Cathyryne Manner

    Vice President

    Total calculated
    $188,815
    From this org
    $170,208
    From related orgs
    $0
    Other
    $18,607
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $170,208
    Bonus
    not reported
    Other
    not reported
    Deferred
    $7,798
    Nontaxable benefits
    $10,809
    Filer's total
    $188,815
  • Jim Geraghty

    Chair

    Total calculated
    $0
    Hours/week
    2
  • Rachel King

    Director

    Total calculated
    $0
    Hours/week
    1
  • Ruth Atherton

    Director

    Total calculated
    $0
    Hours/week
    1
  • Belinda Termeer

    Director

    Total calculated
    $0
    Hours/week
    1
  • Dr Julie Gralow

    Director

    Total calculated
    $0
    Hours/week
    1
  • Seringe Magueye Gueye

    Director

    Total calculated
    $0
    Hours/week
    1
  • J Leighton Read MD

    Director

    Total calculated
    $0
    Hours/week
    1
  • John Nevergole

    Director

    Total calculated
    $0
    Hours/week
    2

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

  • 2024
    Revenue
    $504,858
    Expenses
    $2,591,563
    Contributions
    $504,858
    Grants paid
    $0
  • 2023
    Revenue
    $4,702,895
    Expenses
    $2,437,035
    Contributions
    $4,702,893
    Grants paid
    $0
  • 2022
    Revenue
    $1,971,687
    Expenses
    $2,227,074
    Contributions
    $1,971,618
    Grants paid
    $58,320

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

  • 2021 · 990

    Revenue
    $3,211,056
    Expenses
    $2,124,020
    Assets (EOY)
    $5,318,274
  • 2020 · 990

    Revenue
    $4,396,021
    Expenses
    $1,662,747
    Assets (EOY)
    $4,194,099
  • 2019 · 990

    Revenue
    $1,637,421
    Expenses
    $1,841,899
    Assets (EOY)
    $1,454,032
  • 2019 · 990

    Revenue
    $2,120,671
    Expenses
    $1,834,552
    Assets (EOY)
    $1,415,465
  • 2017 · 990

    Revenue
    $2,135,139
    Expenses
    $1,943,256
    Assets (EOY)
    $1,361,784
  • 2016 · 990

    Revenue
    $1,728,998
    Expenses
    $1,867,508
    Assets (EOY)
    $1,165,063
  • 2015 · 990

    Revenue
    $1,766,106
    Expenses
    $1,560,942
    Assets (EOY)
    $1,284,313
  • 2014 · 990

    Revenue
    $1,189,276
    Expenses
    $1,171,175
    Assets (EOY)
    $1,073,183
  • 2013 · 990

    Revenue
    $927,738
    Expenses
    $705,081
    Assets (EOY)
    $1,135,981
  • 2012 · 990

    Revenue
    not reported
    Expenses
    $3,249,906
    Assets (EOY)
    $1,242,760

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all. Showing the 10 most recent; the API carries the rest.

Grants made

No itemized grants to organizations. Schedule I is filed only by organizations that granted more than $5,000 to a recipient, so most filers have none.

Grants received

Other IRS files

Auto-Revocation List

Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.

Publication 78

Listed as of 13 October 2026, under deductibility PC.

These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.

What this page reflects

The registration facts above come from the IRS Business Master File published 13 October 2026 and read 1 November 2026, for every organization at once. Returns through tax year 2024, the newest we have parsed for this organization.